Cargando…

Prolonged Large Seroma Formation after Breast-Conserving Therapy

A 78-year-old obese woman with breast cancer underwent breast-conserving surgery and axillary lymph node dissection. Due to the prior exposure to long-term taxan chemotherapy for her recurrent gastric cancer, the patient did not undergo adjuvant chemotherapy and began to receive radiotherapy to both...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shuhei, Oura, Shoji, Makimoto, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035919/
https://www.ncbi.nlm.nih.gov/pubmed/35529287
http://dx.doi.org/10.1159/000522557
_version_ 1784693406294867968
author Suzuki, Shuhei
Oura, Shoji
Makimoto, Shinichiro
author_facet Suzuki, Shuhei
Oura, Shoji
Makimoto, Shinichiro
author_sort Suzuki, Shuhei
collection PubMed
description A 78-year-old obese woman with breast cancer underwent breast-conserving surgery and axillary lymph node dissection. Due to the prior exposure to long-term taxan chemotherapy for her recurrent gastric cancer, the patient did not undergo adjuvant chemotherapy and began to receive radiotherapy to both the conserved breast and supraclavicular region on the 39th day after operation. Two aspiration therapies were done to the enlarging seroma only at the initial phase of the radiotherapy. No further aspiration therapies were done to the seroma during and after radiotherapy for more than 3 months despite the undoubtable seroma formation. High degree of tension due to large seroma formation, extended from the axilla to deep into the breast parenchyma, made the patient request us to heal the long-lasting seroma. Five aspiration therapies and one simultaneous minocycline intrathecal injection therapy did not bring about wound healing. To heal the persistent seroma, capsulectomy was done to the encapsulated lesion 7 months after the operation. Resected capsule was 110 × 45 mm in size and had smooth inner surface. Pathological study showed the seroma capsule mainly consisting of fibrous tissue with some inflammatory changes. Postoperative course was uneventful, and wound healing was promptly obtained after capsulectomy. Breast surgeons and radiation oncologists should note this type of unfavorable radiation-induced adverse event after breast-conserving therapy.
format Online
Article
Text
id pubmed-9035919
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-90359192022-05-06 Prolonged Large Seroma Formation after Breast-Conserving Therapy Suzuki, Shuhei Oura, Shoji Makimoto, Shinichiro Case Rep Oncol Case Report A 78-year-old obese woman with breast cancer underwent breast-conserving surgery and axillary lymph node dissection. Due to the prior exposure to long-term taxan chemotherapy for her recurrent gastric cancer, the patient did not undergo adjuvant chemotherapy and began to receive radiotherapy to both the conserved breast and supraclavicular region on the 39th day after operation. Two aspiration therapies were done to the enlarging seroma only at the initial phase of the radiotherapy. No further aspiration therapies were done to the seroma during and after radiotherapy for more than 3 months despite the undoubtable seroma formation. High degree of tension due to large seroma formation, extended from the axilla to deep into the breast parenchyma, made the patient request us to heal the long-lasting seroma. Five aspiration therapies and one simultaneous minocycline intrathecal injection therapy did not bring about wound healing. To heal the persistent seroma, capsulectomy was done to the encapsulated lesion 7 months after the operation. Resected capsule was 110 × 45 mm in size and had smooth inner surface. Pathological study showed the seroma capsule mainly consisting of fibrous tissue with some inflammatory changes. Postoperative course was uneventful, and wound healing was promptly obtained after capsulectomy. Breast surgeons and radiation oncologists should note this type of unfavorable radiation-induced adverse event after breast-conserving therapy. S. Karger AG 2022-04-04 /pmc/articles/PMC9035919/ /pubmed/35529287 http://dx.doi.org/10.1159/000522557 Text en Copyright © 2022 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Suzuki, Shuhei
Oura, Shoji
Makimoto, Shinichiro
Prolonged Large Seroma Formation after Breast-Conserving Therapy
title Prolonged Large Seroma Formation after Breast-Conserving Therapy
title_full Prolonged Large Seroma Formation after Breast-Conserving Therapy
title_fullStr Prolonged Large Seroma Formation after Breast-Conserving Therapy
title_full_unstemmed Prolonged Large Seroma Formation after Breast-Conserving Therapy
title_short Prolonged Large Seroma Formation after Breast-Conserving Therapy
title_sort prolonged large seroma formation after breast-conserving therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035919/
https://www.ncbi.nlm.nih.gov/pubmed/35529287
http://dx.doi.org/10.1159/000522557
work_keys_str_mv AT suzukishuhei prolongedlargeseromaformationafterbreastconservingtherapy
AT ourashoji prolongedlargeseromaformationafterbreastconservingtherapy
AT makimotoshinichiro prolongedlargeseromaformationafterbreastconservingtherapy